Gyre Therapeutics, Inc. (GYRE)
NASDAQ·Healthcare·Biotechnology
$6.20
+1.47%
Mkt Cap $525.50M
Analyst Ratings
No recent rating data.
Price Target (2 analysts)
$17.00
Range $16.00 – $18.00
Implied Upside
+174.2%
Consensus $17.00 vs current $6.20
NASDAQ·Healthcare·Biotechnology
$6.20
+1.47%
Mkt Cap $525.50M
No recent rating data.
Price Target (2 analysts)
$17.00
Range $16.00 – $18.00
+174.2%
Consensus $17.00 vs current $6.20